The catalytic phosphoinositol 3-kinase isoform p110δ is required for glioma cell migration and invasion
about
PI3K isoform-selective inhibitors: next-generation targeted cancer therapiesTargeting the RAS oncogene.Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical developmentTargeting class IA PI3K isoforms selectively impairs cell growth, survival, and migration in glioblastoma.Identifying molecular features associated with psychoneurological symptoms in women with breast cancer using multivariate mixed models.Different inhibition of Gβγ-stimulated class IB phosphoinositide 3-kinase (PI3K) variants by a monoclonal antibody. Specific function of p101 as a Gβγ-dependent regulator of PI3Kγ enzymatic activity.PI3K p110β isoform synergizes with JNK in the regulation of glioblastoma cell proliferation and migration through Akt and FAK inhibition.p87 and p101 subunits are distinct regulators determining class IB phosphoinositide 3-kinase (PI3K) specificityTargeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding.Systematic review of protein biomarkers of invasive behavior in glioblastoma.PTEN and PI3K/AKT in non-small-cell lung cancer.FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration.Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110δ.Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination.The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma.CXCL12-mediated murine neural progenitor cell movement requires PI3Kβ activation.
P2860
Q26781294-52BCBDB5-C88E-458B-A360-43B0D9F4F740Q27687198-3F63BEAE-9F82-4E13-BE94-2A1AFEB9BE62Q33776641-A5DD2617-55B8-4B54-8100-F0190942883AQ35143738-843B175F-EAE3-495E-B002-C91592AF7212Q35591916-528A2DDA-595E-4CBF-8F49-0D302B48486CQ36306280-4EEFE557-DBDA-45A0-8EBF-9E207172A2C9Q36899519-1932CC28-ADAA-4437-BCBA-1FE7756BB53BQ37312165-D632BCB6-E0A7-46D4-9196-AF67E546F14AQ38102636-25300473-E1EB-4396-A628-02C4B072198EQ38165795-5D3100D5-D082-4140-B925-0EA219691484Q38629644-531001E0-EE75-475F-9FB6-A54C644B307CQ39120137-E3F14003-FA7D-4C5B-B9FA-7501A368F4F7Q39121775-AC457AF6-6302-4020-9AC8-123F0965FE47Q43400612-C8480601-A5CC-4C7E-B5E4-5A2BCEFECA4AQ47868509-50F72EC9-D406-4FB0-97C4-0B42DB7485E9Q51054172-D190B215-DA6F-4794-84BC-DE67CFDE6E3B
P2860
The catalytic phosphoinositol 3-kinase isoform p110δ is required for glioma cell migration and invasion
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The catalytic phosphoinositol ...... ma cell migration and invasion
@ast
The catalytic phosphoinositol ...... ma cell migration and invasion
@en
The catalytic phosphoinositol ...... ma cell migration and invasion
@en-gb
The catalytic phosphoinositol ...... ma cell migration and invasion
@nl
type
label
The catalytic phosphoinositol ...... ma cell migration and invasion
@ast
The catalytic phosphoinositol ...... ma cell migration and invasion
@en
The catalytic phosphoinositol ...... ma cell migration and invasion
@en-gb
The catalytic phosphoinositol ...... ma cell migration and invasion
@nl
prefLabel
The catalytic phosphoinositol ...... ma cell migration and invasion
@ast
The catalytic phosphoinositol ...... ma cell migration and invasion
@en
The catalytic phosphoinositol ...... ma cell migration and invasion
@en-gb
The catalytic phosphoinositol ...... ma cell migration and invasion
@nl
P2093
P3181
P1476
The catalytic phosphoinositol ...... ma cell migration and invasion
@en
P2093
Bernd Nürnberg
Roland P Piekorz
Shing-Shun Tony To
Sze Ki Luk
P304
P3181
P356
10.1016/J.EJCA.2011.09.006
P407
P577
2012-01-01T00:00:00Z